Guidelines for pre-clinical animal and cellular models of MuSK-myasthenia gravis.
Muscle-specific tyrosine kinase (MuSK) autoantibodies are the hallmark of a form of myasthenia gravis (MG) that can challenge the neurologist and the experimentalist. The clinical disease can be difficult to treat effectively. MuSK autoantibodies affect the neuromuscular junction in several ways. Wh...
Principais autores: | Phillips, W, Christadoss, P, Losen, M, Punga, A, Shigemoto, K, Verschuuren, J, Vincent, A |
---|---|
Formato: | Journal article |
Idioma: | English |
Publicado em: |
Academic Press Inc.
2015
|
Registros relacionados
-
Myasthenia gravis with MuSK antibodies
por: Farrugia, M, et al.
Publicado em: (2005) -
The role of muscle-specific tyrosine kinase (MuSK) and mystery of MuSK myasthenia gravis.
por: Koneczny, I, et al.
Publicado em: (2014) -
The role of muscle-specific tyrosine kinase (MuSK) and mystery of MuSK myasthenia gravis
por: Koneczny, I, et al.
Publicado em: (2014) -
Potential mechanisms in MuSK-myasthenia gravis
por: Koneczny, I
Publicado em: (2014) -
MuSK-Myasthenia Gravis Unmasked by Hydroxychloroquine
por: Shalini Bhaskar, et al.
Publicado em: (2022-01-01)